CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.07 | 0.10 | 0.24 | 0.40 | |
| 0.77 | 0.68 | 0.01 | 0.01 | 0.77 | 0.73 | 0.00 | 0.01 | 0.96 | 0.00 | 0.00 | 0.00 | 0.86 | |
| 0.01 | -0.68 | 0.01 | 0.01 | -0.77 | -0.73 | 0.00 | 0.01 | 0.00 | 0.07 | 0.10 | 0.24 | 0.40 | |
| 0.77 | 0.68 | 0.74 | 0.74 | 0.77 | 0.73 | 0.82 | 0.86 | 0.96 | 0.90 | 0.96 | 0.95 | 3.56 | |
| 0.27 | 0.25 | 0.29 | 0.31 | 0.32 | 0.31 | 0.38 | 0.53 | 0.55 | 0.57 | 0.49 | 0.55 | 2.03 | |
| 1.04 | 0.25 | 1.03 | 1.05 | 0.32 | 0.31 | 1.20 | 1.39 | 1.51 | 1.49 | 1.45 | 1.49 | 5.60 | |
| -1.04 | -0.93 | -1.02 | -1.05 | -1.10 | -1.04 | -1.20 | -1.38 | -1.51 | -1.42 | -1.35 | -1.25 | -5.20 | |
| -1.01 | -0.90 | -0.93 | -0.94 | -0.96 | -0.88 | -1.04 | -1.23 | -1.38 | -1.30 | -1.23 | -1.14 | -4.75 | |
| 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | 0.00 | – | – | – | |
| -1.01 | -0.90 | -0.93 | -0.94 | -0.96 | -0.88 | -1.04 | -1.23 | -1.38 | -1.31 | -1.23 | -1.14 | -4.75 | |
| -1.01 | -0.89 | -0.92 | -0.93 | -0.95 | -0.87 | -1.03 | -1.22 | -1.37 | -1.29 | -1.22 | -1.24 | -4.82 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.